<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Colucci M</submitter><funding>Associazione Italiana per la Ricerca sul Cancro</funding><funding>Ministero della Salute</funding><funding>Worldwide Cancer Research</funding><pagination>92</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10588013</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>11(1)</volume><pubmed_abstract>T-cell lymphoblastic acute leukemia (T-ALL) is an aggressive blood cancer, characterized by restricted cellular subsets with enriched leukemia initiating cells (LICs). Recently, Ephrin receptors (Eph) were described to be highly expressed in cancer stem cells. Here, using public RNA-Seq datasets of human T-ALL, we reported that EphB6 was the only member within the Eph family overexpressed in over 260 samples. We also found the highest level of EphB6 in a minor cell subpopulation within bulk tumors of patient-derived xenografts, obtained through the injection of primary patient biopsy material into immunocompromised NOD-Scid/IL2Rγc&lt;sup>-/-&lt;/sup> (NSG) mice. Interestingly, this EphB6 positive (EphB6+) subset showed an enriched LIC activity after in vivo transplantation into NSG mice. Additio</pubmed_abstract><journal>Biomarker research</journal><pubmed_title>A functional role of Ephrin type-B receptor 6 (EPHB6) in T-cell acute lymphoblastic leukemia.</pubmed_title><pmcid>PMC10588013</pmcid><funding_grant_id>GR-2011-02351534</funding_grant_id><funding_grant_id>Progetto Ricerca Corrente 2020-2023</funding_grant_id><funding_grant_id>20-0318</funding_grant_id><funding_grant_id>IG-23070</funding_grant_id><pubmed_authors>Tamiro F</pubmed_authors><pubmed_authors>Rossi G</pubmed_authors><pubmed_authors>Trivieri N</pubmed_authors><pubmed_authors>Colucci M</pubmed_authors><pubmed_authors>Giambra V</pubmed_authors><pubmed_authors>Visioli A</pubmed_authors><pubmed_authors>Pracella R</pubmed_authors><pubmed_authors>Sansico F</pubmed_authors><pubmed_authors>Mencarelli G</pubmed_authors><pubmed_authors>De Santis E</pubmed_authors><pubmed_authors>Binda E</pubmed_authors><pubmed_authors>Barile C</pubmed_authors></additional><is_claimable>false</is_claimable><name>A functional role of Ephrin type-B receptor 6 (EPHB6) in T-cell acute lymphoblastic leukemia.</name><description>T-cell lymphoblastic acute leukemia (T-ALL) is an aggressive blood cancer, characterized by restricted cellular subsets with enriched leukemia initiating cells (LICs). Recently, Ephrin receptors (Eph) were described to be highly expressed in cancer stem cells. Here, using public RNA-Seq datasets of human T-ALL, we reported that EphB6 was the only member within the Eph family overexpressed in over 260 samples. We also found the highest level of EphB6 in a minor cell subpopulation within bulk tumors of patient-derived xenografts, obtained through the injection of primary patient biopsy material into immunocompromised NOD-Scid/IL2Rγc&lt;sup>-/-&lt;/sup> (NSG) mice. Interestingly, this EphB6 positive (EphB6+) subset showed an enriched LIC activity after in vivo transplantation into NSG mice. Additio</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 Oct</publication><modification>2026-07-14T20:02:41.852Z</modification><creation>2025-05-29T19:21:45.149Z</creation></dates><accession>S-EPMC10588013</accession><cross_references><pubmed>37858274</pubmed><doi>10.1186/s40364-023-00531-3</doi></cross_references></HashMap>